Revised April 12, 2007
XIII.i.3.E.1.aChemotherapy Program Adopted by the Service Departments
Individuals who receive tuberculin tests sometimes show a change from negative to positive without any other evidence of a tuberculosis infection. The military service departments have adopted a program of chemotherapy for personnel who had a negative tuberculin test on entrance into service, but who were found to have converted to positive during service.
XIII.i.3.E.1.bPolicy on Chemotherapy Treatments
Chemotherapy prescribed for personnel testing positive for tuberculin reaction is to be continued over a 12-month period to reduce the possibility of subsequently acquiring tuberculosis. Important: A positive tuberculin reaction without any other evidence of a tuberculosis infection is not a disease or disability and is not a reason for discharge from service.
XIII.i.3.E.1.cChemotherapy for Discharged Personnel
At the request of the military service departments, Department of Veteran Affairs medical facilities provide continued chemotherapy for the remainder of the 12-month period to discharged personnel who tested positive for tuberculosis during service. After treatment, the medical facility forwards _VA Form 10-7131, Exchange of Beneficiary Information and Request for Administrative and Adjudicative Action, _to the regional office with the following legend: _ _ Medical care being authorized for positive reaction to tuberculin test on basis of prima facie evidence of eligibility.
XIII.i.3.E.1.dProcessing VA Form 10-7131 for Discharged Personnel Testing Positive for Tuberculosis
Follow the steps in the table below when you receive _VA Form 10-7131 _is received for discharged personnel testing positive for tuberculosis.
| Step | Action |
|---|---|
| 1 | Interpret _VA Form 10-7131 _to mean there is no disease or disability present. |
| 2 | Associate _VA Form 10-7131 _with the claims folder without any control. Notes:
|
Reference: For more information on compensation claims based on a positive tuberculin reaction, see M21-1, Part VIII, Subpart iii, 2.A.
End of Part XIII, Subpart i, Chapter 3, Section E